Role of Natural Bioactive Compounds in the Rise and Fall of Cancers : Volume 2

Recent years have seen the idea of a close association between nutrition and the modulation of cancer development/progression reinforced. An increasing amount of experimental and epidemiological evidence has been produced supporting the concept that many different bioactive components of food (e.g....

Full description

Saved in:
Bibliographic Details
Sonstige:
Year of Publication:2020
Language:English
Physical Description:1 electronic resource (318 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 07105nam-a2202077z--4500
001 993545456304498
005 20231214133155.0
006 m o d
007 cr|mn|---annan
008 202105s2020 xx |||||o ||| 0|eng d
035 |a (CKB)5400000000043034 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/69198 
035 |a (EXLCZ)995400000000043034 
041 0 |a eng 
100 1 |a Luparello, Claudio  |4 edt 
245 1 0 |a Role of Natural Bioactive Compounds in the Rise and Fall of Cancers  |b Volume 2 
246 |a Role of Natural Bioactive Compounds in the Rise and Fall of Cancers  
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2020 
300 |a 1 electronic resource (318 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a Recent years have seen the idea of a close association between nutrition and the modulation of cancer development/progression reinforced. An increasing amount of experimental and epidemiological evidence has been produced supporting the concept that many different bioactive components of food (e.g. polyphenols, mono- and polyunsaturated fatty acids, methyl-group donors, etc.) may be implicated in either the promotion of or the protection against carcinogenesis. At the cellular level, such compounds can have an impact on different but sometimes intertwined processes, such as growth and differentiation, DNA repair, programmed cell death, and oxidative stress. In addition, compelling evidence is starting to build up of the existence of primary epigenetic targets of dietary compounds, such as oncogenic/oncosuppressor miRNAs or DNA-modifying enzymes, which in turn impair gene expression and function. Since there is a growing interest in the study of the biochemical and molecular role played by food components and its impact on cellular processes and/or gene expressions directed towards the fine-tuning of cancer phenotypes, in this Special Issue researchers contributed with either research or review articles presenting the latest findings on the intracellular pathways and mechanisms affected by natural bioactive dietary molecules. 
546 |a English 
650 7 |a Research & information: general  |2 bicssc 
650 7 |a Biology, life sciences  |2 bicssc 
653 |a berberine 
653 |a signaling pathways 
653 |a oncogenic cascades 
653 |a TRAIL 
653 |a microRNAs 
653 |a cancer therapy 
653 |a colon cancer cells 
653 |a ethanol 
653 |a Nrf2 
653 |a HO-1 
653 |a ER stress 
653 |a autophagy 
653 |a MMPs 
653 |a formononetin 
653 |a cancer 
653 |a preclinical models 
653 |a cell signaling 
653 |a angiogenesis 
653 |a nobiletin 
653 |a colorectal cancer 
653 |a chemoprevention 
653 |a bioactivities 
653 |a experimental therapeutics 
653 |a HDAC 
653 |a multiple myeloma 
653 |a oleacein 
653 |a breast cancer 
653 |a persistent organic pollutants 
653 |a breast cancer risk 
653 |a breast cancer prognostic 
653 |a systematic review 
653 |a carrageenan 
653 |a invasion 
653 |a metastasis 
653 |a RacGAP1 
653 |a radiotherapy 
653 |a marine sponge 
653 |a natural product 
653 |a anticancer drug 
653 |a oral cancer inhibition 
653 |a phytochemicals 
653 |a small organic agents 
653 |a Piper eriopodon, alkenylphenols 
653 |a human cancer cells 
653 |a cell death 
653 |a apoptosis 
653 |a caspase-independent cell death 
653 |a XIAP antagonists 
653 |a XIAP-BIR3 domain 
653 |a Calocedrus formosana 
653 |a lung cancer 
653 |a yatein 
653 |a cell-cycle arrest 
653 |a xenograft 
653 |a isorhamnetin 
653 |a G2/M arrest 
653 |a ROS 
653 |a AMPK 
653 |a pancreatic cancer 
653 |a epigallocatechin-3-gallate (EGCG) 
653 |a gemcitabine 
653 |a glycolysis 
653 |a phosphofructokinase 
653 |a natural polyphenols 
653 |a anticancer activities 
653 |a molecular mechanisms 
653 |a Streptomyces 
653 |a mangrove 
653 |a anti-proliferative 
653 |a colon cancer 
653 |a epithelial mesenchymal transition 
653 |a inflammation 
653 |a malignant cancer 
653 |a natural anti-inflammatory compounds 
653 |a pro-resolving lipids 
653 |a anticancer drugs 
653 |a flavonoids 
653 |a natural compounds 
653 |a Xenopus laevis 
653 |a AOM/DSS model 
653 |a melanoma cells 
653 |a nicotine 
653 |a α9-nAChR 
653 |a PD-L1 
653 |a STAT3 
653 |a gigantol 
653 |a AKT 
653 |a JAK/STAT 
653 |a cancer stem cell 
653 |a tumor maintenance 
653 |a tumor density 
653 |a proteomics 
653 |a honokiol 
653 |a anticancer 
653 |a mechanism 
653 |a signalling pathway 
653 |a uterine sarcoma 
653 |a fucoidan 
653 |a isobolography 
653 |a colchicine alkaloid 
653 |a mesoporous silica nanoparticles 
653 |a targeted delivery system 
653 |a PD-1 immune checkpoint inhibitor and cancer immunotherapy 
653 |a glucose transport 
653 |a drugs 
653 |a innate immunity 
653 |a β-glucans 
653 |a nutrition 
653 |a immunotherapy 
653 |a estrogen 
653 |a estrogen receptor alpha 
653 |a polyphenols 
653 |a daidzein 
653 |a daidzein metabolites 
653 |a paclitaxel 
653 |a breast cancer cells 
653 |a obesity 
653 |a renin-angiotensin system 
653 |a eicosapentaenoic acid 
653 |a adipocyte inflammation 
653 |a olive leaf extract 
653 |a oleuropein 
653 |a Seahorse analysis 
653 |a cancer metabolism 
653 |a glycolytic markers 
653 |a Malva pseudolavatera Webb &amp 
653 |a Berthel. 
653 |a acute myeloid leukemia 
653 |a reactive oxygen species 
653 |a brain cancer 
653 |a gliomas 
653 |a schwannomas 
653 |a malignant tumors of the peripheral nerve sheath (MPNST) 
653 |a neurofibromas 
653 |a bioavailability 
653 |a nanoparticle-based delivery systems 
653 |a natural bioactive compound 
653 |a gallic acid 
653 |a EGFR signaling 
653 |a p53 
653 |a EGCG 
653 |a non-coding RNAs 
653 |a anti-cancer drug 
653 |a NSCLC 
653 |a EGFR TKI 
653 |a FASN inhibitors 
653 |a resistance 
776 |z 3-03943-292-3 
776 |z 3-03943-293-1 
700 1 |a Luparello, Claudio  |4 oth 
906 |a BOOK 
ADM |b 2023-12-15 05:45:34 Europe/Vienna  |f system  |c marc21  |a 2022-04-04 09:22:53 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337939450004498&Force_direct=true  |Z 5337939450004498  |b Available  |8 5337939450004498